Click Here to return To Results

 

Memantine in Moderate-to-Severe Alzheimer's Disease NEJM 348:1333-1341, Reisberg,B.,et al, 2003 See this aricle in Pubmed Article Abstract Antiglutamatergic treatment reduced clinical deterioration in moderate-to-severe AlzheimerÆs disease, a phase associated with distress for patients and burden on caregivers, for which other treatments are not available.

Related Tags

(click to filter results - removes previous filter) Alzheimer's disease Alzheimer's disease,treatment of memantine NMDA antagonists treatment of neurologic disorder

Click Here to return To Results